Results 141 to 150 of about 28,228 (226)

The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) [PDF]

, 2000
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, Jean‐Pierre Grünfeld, William F. Keane, Kiyoshi Kurokawa, Janet B. McGill, William E. Mitch, Hans Henrik Parving, Giuseppe Remuzzi, Arthur Barcelos Ribeiro, Mark Schluchter, Duane Snavely, Zhongxin Zhang, Roger L. Simpson, Denise Ramjit, Shahnaz Shahinfar, RENAAL Study Investigators   +17 more
openalex   +1 more source

Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension. [PDF]

J Clin Med
Fuchs FD, Valter LK, Tavares AL, Camilo BP, Whelton PK, Scala LCN, Vilela-Martin JF, Poli-de-Figueiredo CE, Silva RPE, Gus M, Bortolotto LA, Schlatter RP, Cesarino EJ, Castro I, Neto JAF, Steffens AA, Alves JG, Brandão AA, Sousa MR, Jardim PC, Moreira LB, Franco RS, Gomes MM, Fuchs FC, Filho DS, Nóbrega AC, Nobre F, Berwanger O, Fuchs SC.   +28 more
europepmc   +1 more source

Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan [PDF]

, 2000
Antonio Núñez, Juan Gómez Rivas, Luis Rico Zalba, Mercedes Montón, Ana Jiménez, Sandra Velasco, Almudena López-Blaya, Ángel Celdrán Uriarte, Santos Casado, Antonio López‐Farré   +9 more
openalex   +1 more source

Inhibition of the Renin-Angiotensin System Improves Hemodynamic Function of the Diabetic Rat Heart by Restoring Intracellular Calcium Regulation. [PDF]

Biomedicines
Paulik KA, Ivanics T, Dunay GA, Fülöp Á, Kerék M, Takács K, Benyó Z, Miklós Z.   +7 more
europepmc   +1 more source

Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after injury [PDF]

, 2000
Jacinthe Lemay, Pavel Hamet, Denis deBlois   +2 more
openalex   +1 more source

Angioedema Shortly After Adding Empagliflozin to Losartan. [PDF]

Cureus
Duodu P, Aiad M, Deeb M, Jan M, Khalil D, Wilson M.   +5 more
europepmc   +1 more source

New Drugs: Losartan potassium

, 1997

openalex   +1 more source

Nitric oxide mediates inhibitory effect of losartan on angiotensin-induced contractions in hamster but not rat aorta [PDF]

, 2000
Kiyo Inoue, Hikaru Nishimura, Jiro Kubota, Yasushi Kitaura   +3 more
openalex   +1 more source

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes

, 2000
Craig Cheetham, Julie Collis, G. O’Driscoll, K. Stanton, Roger R. Taylor, Daniel J. Green   +5 more
openalex   +1 more source

Losartan and Reversible Psychosis

Cardiology, 1996
openaire   +2 more sources